TUBB4A and prostate adenocarcinoma: Overexpression of TUBB4A was evident in last-stage and metastatic prostate adenocarcinomas and was associated with poor patient survival, but there was no genetic alteration of TUBB4A in most of these cancers, suggesting that epigenetic regulation of TUBB4A, such as DNA demethylation, may contribute to its overexpression.